Similar medications and substitutes for MARIBAVIR
In short: Livtencity (MARIBAVIR) belongs to the Cytomegalovirus pUL97 Kinase Inhibitor class. The medications listed below either share that mechanism of action or have been clinically validated as substitutes when Livtencity is unsuitable due to side effects, cost, availability, or contraindications.
No alternatives are listed for Livtencity in our database yet. Browse the full medicine index or consult your pharmacist for substitution advice.